Canakinumab Subcutaneous and Dalacin C Palmitate Oral
Determining the interaction of Canakinumab Subcutaneous and Dalacin C Palmitate Oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: clindamycin
Brand name: Cleocin HCl, Cleocin Pediatric, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage, Clindesse, ClindaMax Vaginal, Cleocin
Synonyms: Clindamycin, Clindamycin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dalbavancin
- Canakinumab Subcutaneous-Dalbavancin Hydrochloride
- Canakinumab Subcutaneous-Dalbavancin Injection
- Canakinumab Subcutaneous-Dalbavancin Intravenous
- Canakinumab Subcutaneous-Dalfampridine
- Canakinumab Subcutaneous-Dalfopristin and quinupristin
- Dalacin C Palmitate Oral-Canasa
- Dalacin C Palmitate Oral-Canasa Pac rectal
- Dalacin C Palmitate Oral-Canasa rectal
- Dalacin C Palmitate Oral-Cancidas
- Dalacin C Palmitate Oral-Candesartan
- Dalacin C Palmitate Oral-Candesartan and Hydrochlorothiazide